Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Last Updated: January 17, 2022

DrugPatentWatch Database Preview

Duramed Pharms Barr Company Profile

Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for DURAMED PHARMS BARR, and what generic and branded alternatives to DURAMED PHARMS BARR drugs are available?

DURAMED PHARMS BARR has sixty-eight approved drugs.

Summary for Duramed Pharms Barr

US Patents:	0
Tradenames:	34
Ingredients:	30
NDAs:	68

Drugs and US Patents for Duramed Pharms Barr

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Duramed Pharms Barr	AVIANE-28	ethinyl estradiol; levonorgestrel	TABLET;ORAL-28	075796-001	Apr 30, 2001	AB1	RX	No	No		⤷ Try it Free				⤷ Try it Free
Duramed Pharms Barr	METHYLDOPA	methyldopa	TABLET;ORAL	071006-001	Dec 16, 1986		DISCN	No	No		⤷ Try it Free				⤷ Try it Free
Duramed Pharms Barr	PREDNISONE	prednisone	TABLET;ORAL	088394-001	Oct 4, 1983		DISCN	No	No		⤷ Try it Free				⤷ Try it Free
Duramed Pharms Barr	CRYSELLE	ethinyl estradiol; norgestrel	TABLET;ORAL-28	075840-002	Nov 30, 2001	AB	RX	No	No		⤷ Try it Free				⤷ Try it Free
Duramed Pharms Barr	ACETAMINOPHEN AND CODEINE PHOSPHATE	acetaminophen; codeine phosphate	TABLET;ORAL	088354-001	Feb 6, 1984		DISCN	No	No		⤷ Try it Free				⤷ Try it Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson

Johnson and Johnson

Colorcon

Express Scripts

Dow

Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.